Secondary infiltration of the central nervous system in patients with diffuse large B-cell lymphoma

Autor: Roberto Pinto Paes, Igor Campos da Silva, Fortier Sergio Costa, Maeva Pinto, Talita Maira Bueno da Silveira da Rocha, Carlos S. Chiattone

Publikováno v: Revista Brasileira de Hematologia e Hemoterapia, Volume: 35, Issue: 4, Pages: 256-262, Published: 2013
Revista Brasileira de Hematologia e Hemoterapia
Revista Brasileira de Hematologia e Hemoterapia v.35 n.4 2013
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Revista Brasileira de Hematologia e Hemoterapia, Vol 35, Iss 4, Pp 256-262 (2013)

OBJECTIVE: To investigate the incidence and risk factors of infiltration of the central nervous system after the initial treatment of diffuse large B-cell lymphoma in patients treated at Santa Casa de Misericórdia de São Paulo. METHODS: A total of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0c99c64673dd4cb798c35943a34d36
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000400256&lng=en&tlng=en

The Oral Mtor Inhibitor Everolimus in Relapsed and Refractory Hodgkin Lymphoma- Compassionate Use in 8 Centers in Brazil

Autor: Andressa Laranja, Rafael Dezen Gaiolla, Guilherme Fleury Perini, N. S. Castro, Maeva Pinto, Sérgio Costa Fortier, José Salvador Oliveira, Marcia Torresan Delamain, Laura Fogliato, Carlos S. Chiattone, Talita Silveira da Rocha, V. Buccheri

Publikováno v: Blood. 126:5107-5107

Purpose- Everolimus is an oral antineoplastic agent that targets the raptor mammalian target of rapamycin (mTORC1). The phosphatidylinositol 3-kinase/mTOR signal transduction pathway has been demonstrated to be activated in tumor samples from patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::677f2d8e42d75f1147270a993f39e4cf
https://doi.org/10.1182/blood.v126.23.5107.5107